comparemela.com

Latest Breaking News On - Orpha co orphazyme - Page 1 : comparemela.com

Statutory restructuring plan adopted by creditors

Orphazyme A/S in restructuringCompany announcementNo. 20/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark,.

John sommer schmidtAnders vadsholtCompany registration noOrpha co orphazymeDanish insolvencyChief executive officerChief financial officerSommer schmidtRestructuring administratorCopenhagen stock exchange orphaOrphazymea s

Correction: Proposal for a statutory restructuring plan

Orphazyme A/S in restructuringCompany announcementNo. 17/2022Inside information www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 4, 2022. | April 4, 2022

John sommer schmidtAnders vadsholtDrug administrationCompany registration noGlobenewswire incOrpha co orphazymeChief executive officerChief financial officerSommer schmidtRestructuring administratorNasdaq copenhagenOrphan drug designationFast track designationBreakthrough therapy designationRare pediatric disease designationComplete response letter

Voluntary delisting of ADSs has become effective

Orphazyme A/S in restructuringCompany announcementNo. 16/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 31, 2022 –.

Anders vadsholtExchange commissionCompany american depositary shares adssCompany adssSecurities exchangeDrug administrationCompany registration noOrpha co orphazymeAmerican depositary sharesNasdaq global select marketNasdaq globalSecurities exchange actChief executive officerChief financial officerNasdaq copenhagenOrphan drug designation

vimarsana © 2020. All Rights Reserved.